AstraZeneca's total assets for Q3 2025 were $114.46B, an increase of 1.81% from the previous quarter. AZN total liabilities were $68.48B for the fiscal quarter, a 1.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.